ArticleBlood2022

Combining nilotinib and PD-L1 blockade reverses CD4+ T-cell dysfunction and prevents relapse in acute B-cell leukemia.

Sean I Tracy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.